Related Experiment Video
Updated: May 8, 2025
05:53
Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
14.9K
Human Cytomegalovirus Replication Enhanced By Placental MicroRNAs.
Kazufumi Ikuta1,2, Misako Yajima1,3, Hiroshi Kitamura1
1Division of Microbiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
Journal of Medical Virology
|December 24, 2024
Summary
Placental trophoblast-specific microRNAs (miRNAs) enhance human cytomegalovirus (HCMV) replication by downregulating RAC2 expression. This finding sheds light on congenital HCMV infection mechanisms and placental viral defense strategies.
Area of Science:
- Reproductive biology
- Virology
- Molecular biology
Background:
- Placental trophoblasts form a barrier against maternal-fetal viral transmission.
- Congenital human cytomegalovirus (HCMV) infection can cause severe fetal complications.
- HCMV is a leading cause of intrauterine infections.
Purpose of the Study:
- To investigate the role of placental trophoblast-specific microRNAs (miRNAs) in HCMV infection.
- To elucidate the mechanisms by which the placental environment influences HCMV replication.
Main Methods:
- Transfection of placental trophoblast cells with C19MC miRNAs.
- Analysis of HCMV Immediate Early (IE) gene expression.
- Gene expression profiling to identify host factors affected by C19MC miRNAs.
- Functional assays to assess the impact of RAC2 suppression on HCMV replication.
Main Results:
- Trophoblast-specific C19MC miRNAs significantly enhanced HCMV IE gene expression and viral production.
- C19MC miRNA transfection did not affect herpes simplex virus type-1 IE gene expression.
- RAC2, a Rac family small GTPase, was identified as a gene markedly suppressed by C19MC miRNA transfection.
- Suppression of RAC2 expression led to enhanced HCMV IE gene expression.
Conclusions:
- Placental trophoblast-specific miRNAs contribute to HCMV-specific replication.
- HCMV replication is facilitated by miRNA-mediated downregulation of RAC2 in trophoblasts.
- This mechanism highlights a potential pathway for congenital HCMV transmission and suggests novel therapeutic targets.
